CD8A and cancer: Some of these memory CD8+ T cells retain killing ability so that in case of a secondary infection or cancer cell appearance, they could respond quickly and efficiently (Böttcher et al., 2015; Gerlach et al., 2016; Kaech et al., 2002; Surh & Sprent, 2008; Wherry et al., 2003).